About | Free Trial

Last Update


This profile was last updated on . .

Is this you? Claim your profile.

Wrong Mitch Dowsett?

Prof. Mitch Dowsett

Professor of Biochemical Endocrinology

Institute of Cancer Research

Direct Phone: +44 ***********       

Institute of Cancer Research

Sir Richard Doll Building 15 Cotswold Road

Sutton, Surrey SM2 5NG

United Kingdom

Company Description

The Institute of Cancer Research is Europe's leading cancer research centre with expert scientists working on cutting edge research. It was founded in 1909 to carry out research into the causes of cancer and to develop new strategies for cancer prevention... more

Find other employees at this company (7,700)

Background Information

Employment History

Founding Chairman

National Cancer Research Institute


Breakthrough Breast Cancer


International Member of the Steering Committee

Oncology Advisory Board Member
Radius Health, Inc.

Executive and/or Steering Committees

Advisory Board Member
Immunovia AB

Translational Research Committees

Member of the Executive Committee
HERA Trial

Planning Committee
Aromatase Inhibitor Overview Group

Member of the Special Awards Committee
American Society of Clinical Oncology

Advisory Board Member
Wales Cancer Bank

Member of the Steering and Executive Committees of Several Prominent International Breast Cancer Trials

NanoString Technologies Inc

Chairman of the Research Committee
NTRAC Translational

Steering Committee

Member of the Executive Board
Breast International Group



Imperial College


Chester Beatty Cancer Research Institute at London University


Institute of Cancer Research

PhD training being

The Institute of Cancer Research

Web References (184 Total References)

Mitch Dowsett, PhD, ...

www.radiuspharm.com [cached]

Mitch Dowsett, PhD, FMedSci

Mitch Dowsett, PhD, FMedSci Mitch Dowsett, PhD, FMedSci, is a clinical scientist who has over 540 papers listed on PubMed. He is Head of the Academic Department of Biochemistry and of the Centre for Molecular Pathology at the Royal Marsden Hospital. He is Professor of Biochemical Endocrinology at the Institute of Cancer Research and of Translational Research in the Breakthrough Breast Cancer Centre in London, UK.
His major research interests involve hormonal aspects of breast cancer and the application of biomarkers in clinical trials. He was a major player in the development of aromatase inhibitors, now the most widely used endocrine agent for postmenopausal breast cancer patients and chairs the Aromatase Inhibitor Overview Group that co-ordinates the collaborative assessment of the merged data from the international trials. He is a member of the ASCO/CAP Steering Committees for guidelines on both HER2 and steroid receptors and he co-chairs the International Working Group on Ki67 in Breast Cancer. He was the founding chairman of the National Cancer Research Institute's Biomarker and Imaging Clinical Study Group.
Professor Dowsett is particularly interested in the evaluation of new and established agents in presurgical studies of breast cancer including being co-PI of the 4,450 patient POETIC trial, the largest study conducted to date. He sits on the Executive and/or Steering Committees of many international trials and served for 7 years on the Executive Committee of the Breast International Group (BIG).
He has received the William L. McGuire Award and the Brinker Award for Scientific Distinction and has given multiple named lectures.

Prof. Mitch ...

immunovia.com [cached]

Prof. Mitch Dowsett

Head of the Academic Department of Biochemistry and Head of Breast Cancer Translational Research, Royal Marsden Hospital and Institute of Cancer Research, London, England

Pharmacy news - Daily Online Canadian Pharmacy News Articles

www.universaldrugstore.com [cached]

The first study was led by Mitch Dowsett, of The Royal Marsden Hospital and The Institute of Cancer Research, and assessed over 30,000 early breast cancer patients who were postmenopausal. The women took an AI or tamoxifen, the standard treatment drug, for five years. The AI group saw a 15 percent drop in risk of death and 30 percent reduction in risk of cancer. Dowsett said, "Our global collaboration has revealed that the risk of postmenopausal women with the most common form of breast cancer dying of their disease is reduced by 40 percent by taking five years of an AI - a significantly greater protection than that offered by tamoxifen."

Radius Health also announced ...

boston.citybizlist.com [cached]

Radius Health also announced today that it has formed an Oncology Clinical Advisory Board (OCAB) comprised initially of two renowned leaders in the field of oncology: Professor Mitch Dowsett, FMedSci, PhD, and Professor George W. Sledge Jr.

In addition, we are honored to have the esteemed counsel of two of the leading authorities in the field of breast cancer research, Professor Dowsett and Professor Sledge, join our newly formed OCAB," said Radius Health CEO, Robert E. Ward.
Radius is pleased to announce the formation of the OCAB with its first two members, both of whom are world renowned scientific and clinical authorities in the field of oncology: Professor Mitch Dowsett, and Professor George Sledge.
Professor Mitch Dowsett, FMedSci, PhD, is Head of the Academic Department of Biochemistry and Head of the Centre for Molecular Pathology at the Royal Marsden Hospital in London, UK. He is also Professor of Biochemical Endocrinology at the Institute of Cancer Research, Professor of Translational Research in the Breakthrough Breast Cancer Centre, Team Leader for Breast Cancer Research for the Biomedical Research Centre for Cancer and Leader of the Endocrinology Team at the Breakthrough Breast Cancer Centre. Dr. Dowsett's main scientific interests have been related to the endocrine basis of the majority of breast cancers, and his studies to understand the mechanisms of response and resistance to estrogen deprivation in the treatment of breast cancer. His studies led to the development of aromatase inhibitors.

"But aromatase inhibitor treatment is not ...

www.thejakartapost.com [cached]

"But aromatase inhibitor treatment is not free of side-effects and it's important to ensure that women" who suffer them are "supported", said the study's lead author, Mitch Dowsett of The Institute of Cancer Research in London.

Similar Profiles

Other People with this Name

Other people with the name Dowsett

Paul Dowsett
Scott Morris Architects Inc

Ashley Dowsett
Dunning Investments Pty Ltd

Kathryn Dowsett
Lidget Green

Vicky Dowsett
Bromley Symphony Orchestra

Lauren Dowsett
Dacorum Borough Council

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory